A recent report of a case-control study from The Netherlands (de Jong et al) reported an association of breast implants with anaplastic large T-cell lymphoma, however the study had limitations and referred only to saline implants.
In a recent issue of the Plastic and Reconstructive Surgery Journal, an article by Lipworth et al examined this issue. To determine whether breast implants are associated with an increased lymphoma risk, the authors have reviewed the evidence from five long-term follow-up studies that looked at the incidence of non-Hodgkin’s lymphoma in breast implant patients. These studies involved over 43,000 women with cosmetic breast implants, who were observed over 37 years.
In this group of 43 000, 48 women developed non-Hodgkin’s lymphoma. An average group of any 43 000 women would be expected to have 53.9 cases. This leads to a conclusion that breast implants do not increase the risk of non-Hodgkin’s lymphoma as compared to the average female population.
Based on the epidemiologic studies published to date, there is no evidence of an excess of non-Hodgkin’s lymphoma incidence overall among women with cosmetic silicone-filled breast implants.
Thus Breast Implants remain safe and do not cause rare illnesses.
Martin Jugenburg,MD, FRCSC
Toronto, ON